$MOBI

Green Park & Golf Ventures - Houston, LLC purchased $908K of MOBI (indirect holdings)

Green Park & Golf Ventures - Houston, LLC purchased 60,537 indirectly-held shares of Mobia Medical, Inc. (MOBI) at $15.00 ($0.91M total) on 2026-05-11.

Original reporting
SEC EDGAR · Green Park & Golf Ventures - Houston, LLC
Published Jun 29, 2026, 11:59 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$MOBI
Bullish
medium confidence
Mentioned
$MOBI
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MOBIBullishLow
01

Why it matters

The newest disclosed fact is the 10% owner’s open-market purchase of 60,537 shares at $15.00/share, totaling $908,055, with holdings after the transaction reported as 60,537 shares.

02

Market read

Insider buying can modestly support sentiment, but the disclosure lacks accompanying fundamental catalysts (no guidance, deal, or regulatory event).

03

What to watch

The filing notes no pre-arranged 10b5-1 plan; traders may still discount the signal because the purchase date (2026-05-11) precedes the filing by weeks.

Relevance 6/10Novelty 5/10Timing: Form 4 filed 2026-06-29; transaction dated 2026-05-11

Background

The article is an SEC Form 4 insider transaction disclosure for Mobia Medical, Inc. (MOBI).

Company-level read

Ticker impact

$MOBIBullishMedium confidence
Context

Green Park & Golf Ventures - Houston, LLC (10% owner) bought 60,537 MOBI shares in an open-market purchase for $908,055.

Expected impact

Likely modest, short-lived sentiment support; no clear directional catalyst beyond ongoing insider activity.

Evidence & confidence

The filing is a primary-source insider transaction with a defined size and price ($15/share), but it is not tied to earnings, guidance, deals, or regulatory actions.

Market effects

No sector-wide read-across; this is company-specific insider buying.

None indicated.

None indicated.

Counterpoint

A single open-market purchase by an indirect 10% owner may reflect diversification or pre-existing liquidity needs rather than a new bullish thesis.

Key entities

  • Mobia Medical, Inc.

    Subject of the Form 4 insider transaction; ticker MOBI.

  • Green Park & Golf Ventures - Houston, LLC

    10% owner who purchased MOBI shares indirectly via open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MOBIHigh

Mobia Medical stock jumps on stroke guideline inclusion

Mobia Medical Inc (MOBI) shares rose 7.2% premarket after the American Heart Association included its paired vagus nerve stimulation in 2026 stroke rehabilitation guidelines. The Vivistim Paired VNS System is the only FDA-approved system for this treatment, which may improve upper-limb function. Stroke is a leading cause of long-term disability in the U.S.

$MOBIMedAI 8/10

Mobia Medical (MOBI) Q2 2026 Earnings Call Transcript

Mobia Medical (MOBI) reported Q2 2026 revenue of $13.5M, up 102% YoY, driven by Vivistim system adoption. Full-year guidance set at $54M-$56M. Net loss was $21M, with cash reserves of $177.1M post-IPO. Management plans to expand active territories and target 1,500 U.S. stroke centers.

$MOBIMed

Mobia Medical, Inc. (MOBI): Results of Operations and Financial Condition

Mobia Medical, Inc. (MOBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mobia Medical Reports Second Quarter 2026 Financial Results Austin, Texas, August 11, 2026 — Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported financial re

$MOBIMedAI 8/10

Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapy

Mobia Medical (Nasdaq: MOBI) said Neurology published two-year follow-up results from its VNS-REHAB trial of Vivistim Paired VNS Therapy in chronic ischemic stroke. Among 49 participants, 76% met response on FMA-UE and/or WMFT, with average gains of +7.5 FMA-UE and +0.63 WMFT. Mobia reported improvements in daily living and quality of life sustained for at least two years.